Covid Probably Leaked

Paxlovid may help some long COVID patients: Research

A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long COVID when administered outside of an infection. Administration of Paxlovid ...

The Hill - Jan. 6

Djokovic still has 'trauma' over Covid deportation

Novak Djokovic says he still has "trauma" when he visits Melbourne, three years after being deported because of Covid-19 rules.

BBC News - Jan. 6

Paxlovid Improved Long Covid Symptoms in Some Patients, Researchers Report

But the report, on the experiences of 13 patients, found that the drug had no benefit for some people and that some who benefited said the improvement didn’t last.

The New York Times - Jan. 6

Kinzinger on 'changed' GOP: 'I'm probably closer to a Democrat now'

Former Rep. Adam Kinzinger (R-Ill.) reflected on the “changed” Republican Party, saying he finds himself being “probably closer to a Democrat now” politically, arguing the Democratic Party is ...

The Hill - Jan. 5

Covid surges across US after holidays amid low booster uptake

Test positivity, emergency room visits, hospitalizations and deaths are increasing as expert warns: ‘It’s still dangerous’. . Covid is once again surging across the US after an unusual relative ...

The Guardian - Jan. 3

Elon Musk, Vivek Ramaswamy call remote work a 'Covid-era privilege.' Economists say it's here to stay

Economists say the work-from-home trend, which was widespread during the pandemic, won't diminish to its pre-Covid level because it's profitable for employers.

CNBC - Jan. 2

5 things we know and still don't know about COVID, 5 years after it appeared

Five years after the virus that causes COVID emerged in China it still holds some mysteries

ABC News - Jan. 2

5 things we know and still don't know about COVID, 5 years after it appeared

Five years after the virus that causes COVID emerged in China it still holds some mysteries

ABC News - Jan. 2

Why Trump should switch sides on the US Steel-Nippon Steel merger (but probably won’t)

The clock is ticking on government approval for the U.S. Steel-Nippon Steel merger, and whether short-term political buffoonery will win out over inexorable economic logic. My money is on buffoonery.

The Hill - Jan. 2